Promising Medical Stocks Worth Watching – November 12th

Stryker, Gilead Sciences, Humana, Medtronic, Boston Scientific, Danaher, and HCA Healthcare are the seven Medical stocks to watch today, according to MarketBeat’s stock screener tool. Medical stocks are shares of companies involved in healthcare, such as pharmaceutical and biotech firms, medical-device makers, and healthcare providers. Investors may buy them to gain exposure to demand for medical products and services, though their performance can depend on factors such as regulation, research results, and healthcare spending. These companies had the highest dollar trading volume of any Medical stocks within the last several days.

Stryker (SYK)

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.

NYSE SYK traded down $1.82 during trading hours on Thursday, reaching $316.97. 1,007,294 shares of the company’s stock were exchanged, compared to its average volume of 2,511,101. The company has a market capitalization of $120.67 billion, a price-to-earnings ratio of 33.76, a price-to-earnings-growth ratio of 2.23 and a beta of 0.78. Stryker has a one year low of $267.00 and a one year high of $389.33. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.30 and a current ratio of 2.18. The company’s 50-day moving average is $292.27 and its two-hundred day moving average is $323.05.

Gilead Sciences (GILD)

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis.

Shares of NASDAQ:GILD traded up $0.32 during midday trading on Thursday, reaching $170.05. 1,689,898 shares of the company were exchanged, compared to its average volume of 6,802,253. The firm has a market cap of $210.92 billion, a PE ratio of -53.87 and a beta of 0.35. Gilead Sciences has a fifty-two week low of $116.88 and a fifty-two week high of $176.58. The stock has a fifty day simple moving average of $154.40 and a two-hundred day simple moving average of $141.51. The company has a quick ratio of 1.22, a current ratio of 1.38 and a debt-to-equity ratio of 1.84.

Humana (HUM)

Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

HUM stock traded down $3.66 during trading hours on Thursday, reaching $442.65. 582,362 shares of the stock were exchanged, compared to its average volume of 1,647,286. The firm’s 50-day moving average is $406.79 and its 200-day moving average is $314.80. Humana has a 12 month low of $163.11 and a 12 month high of $456.50. The company has a market cap of $53.16 billion, a price-to-earnings ratio of 43.11, a PEG ratio of 2.30 and a beta of 0.65. The company has a debt-to-equity ratio of 0.61, a current ratio of 1.65 and a quick ratio of 1.74.

Medtronic (MDT)

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.

NYSE MDT traded up $0.53 during trading on Thursday, hitting $102.14. The stock had a trading volume of 2,398,568 shares, compared to its average volume of 11,191,393. The company has a market capitalization of $130.65 billion, a PE ratio of 25.14, a P/E/G ratio of 2.38 and a beta of 0.56. Medtronic has a 12 month low of $73.31 and a 12 month high of $106.33. The company’s 50-day moving average price is $93.34 and its two-hundred day moving average price is $88.46. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.54 and a current ratio of 2.07.

Boston Scientific (BSX)

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system.

BSX traded down $0.58 during trading hours on Thursday, hitting $44.55. 5,330,764 shares of the company’s stock were exchanged, compared to its average volume of 18,732,783. The company has a quick ratio of 0.81, a current ratio of 1.36 and a debt-to-equity ratio of 0.42. Boston Scientific has a 1-year low of $39.57 and a 1-year high of $105.65. The stock’s 50-day moving average is $44.13 and its two-hundred day moving average is $54.99. The stock has a market cap of $64.58 billion, a price-to-earnings ratio of 18.85, a PEG ratio of 1.32 and a beta of 0.60.

Danaher (DHR)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Shares of NYSE:DHR traded down $0.93 during midday trading on Thursday, reaching $234.38. The company had a trading volume of 904,168 shares, compared to its average volume of 4,425,780. Danaher has a 1-year low of $160.93 and a 1-year high of $242.80. The stock has a market cap of $164.89 billion, a PE ratio of 38.36, a P/E/G ratio of 2.96 and a beta of 0.76. The company has a quick ratio of 1.29, a current ratio of 1.63 and a debt-to-equity ratio of 0.45. The business’s 50 day moving average price is $221.67 and its 200 day moving average price is $201.56.

HCA Healthcare (HCA)

HCA Healthcare, Inc., through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Shares of HCA Healthcare stock traded up $1.64 on Thursday, reaching $507.68. 308,711 shares of the company were exchanged, compared to its average volume of 1,347,229. The company has a 50-day moving average of $449.06 and a 200 day moving average of $445.81. The company has a market capitalization of $106.05 billion, a price-to-earnings ratio of 16.82, a PEG ratio of 1.68 and a beta of 1.11. HCA Healthcare has a one year low of $353.99 and a one year high of $556.52.